Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
JAK2 Targeted Mutation Analysis (V617F) Genetics Center United States | 3 | 1 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Invitae Expanded Renal Disease Panel Invitae United States | 693 | 388 |
|
GenepoweRx Uppaluri K&H Personalized Medicine Clinic India | 27 | 58 |
|
GenepoweRx Uppaluri K&H Personalized Medicine Clinic India | 17 | 41 |
|
Centogene AG - the Rare Disease Company Germany | 195 | 221 |
|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
VEGFA - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
HFE - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 6 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Bone Marrow Failure / Anemia Panel Centogene AG - the Rare Disease Company Germany | 212 | 212 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Invitae Congenital Anomalies of Kidney and Urinary Tract (CAKUT) Panel Invitae United States | 67 | 41 |
|
Invitae Renal Tubular Disorders Panel Invitae United States | 68 | 39 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.